The lncRNA SChLAP1 is a tissue biomarker that can be used to identify prostate cancer patients at high risk of fatal progression, according to a study of prostate cancer patients in the United States (Mehra et al., 2016). The gene discussed is SCHLAP1; the disease is prostate carcinoma.